These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19176893)

  • 1. Cracking the therapeutic nut in mild cognitive impairment: better nuts and better nutcrackers.
    Knopman DS
    Neurology; 2009 May; 72(18):1542-3. PubMed ID: 19176893
    [No Abstract]   [Full Text] [Related]  

  • 2. Mild cognitive impairment: a treatment at last?
    Allain H; Bentué-Ferrer D; Akwa Y
    Lancet Neurol; 2004 Nov; 3(11):643. PubMed ID: 15488455
    [No Abstract]   [Full Text] [Related]  

  • 3. Mild cognitive impairment--no benefit from vitamin E, little from donepezil.
    Blacker D
    N Engl J Med; 2005 Jun; 352(23):2439-41. PubMed ID: 15829528
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
    Stiles MM; Martin S; Persons RK
    J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
    [No Abstract]   [Full Text] [Related]  

  • 5. Mild cognitive impairment and dementia.
    Albert MS; Blacker D
    Annu Rev Clin Psychol; 2006; 2():379-88. PubMed ID: 17716075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCI.
    Salloway S; Correia S; Richardson S
    Int Psychogeriatr; 2008 Feb; 20(1):40-6. PubMed ID: 17597552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?
    Ames D; Kaduszkiewicz H; van den Bussche H; Zimmermann T; Birks J; Ashby D
    Int Psychogeriatr; 2008 Apr; 20(2):259-92. PubMed ID: 18252031
    [No Abstract]   [Full Text] [Related]  

  • 8. No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia.
    Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC
    Cogn Neuropsychiatry; 2007 Sep; 12(5):412-21. PubMed ID: 17690999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mild Cognitive Impairment: potential therapeutics].
    Allain H; Bentue-Ferrer D; Belliard S; Reymann JM; Djemaï M; Merienne M
    Rev Neurol (Paris); 2002; 158(10 Suppl):S35-40. PubMed ID: 12529584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive predictors of donepezil therapy response in Alzheimer disease.
    Saumier D; Murtha S; Bergman H; Phillips N; Whitehead V; Chertkow H
    Dement Geriatr Cogn Disord; 2007; 24(1):28-35. PubMed ID: 17495473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
    Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case series of D-cycloserine added to donepezil in the treatment of Alzheimer's disease.
    Falk WE; Daly EJ; Tsai GE; Gunther J; Brown P
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):466-7. PubMed ID: 12426422
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E and donepezil for the treatment of mild cognitive impairment.
    Petersen RC; Thomas RG; Grundman M; Bennett D; Doody R; Ferris S; Galasko D; Jin S; Kaye J; Levey A; Pfeiffer E; Sano M; van Dyck CH; Thal LJ;
    N Engl J Med; 2005 Jun; 352(23):2379-88. PubMed ID: 15829527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil treatment of patients with MCI: a 48-week randomized, placebo- controlled trial.
    Crane PK; Doody RS
    Neurology; 2009 Nov; 73(18):1514-5; author reply 1515-6. PubMed ID: 19884584
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment?
    Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J
    Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuing donepezil produces cognitive benefits in Alzheimer's.
    Bland P
    Practitioner; 2012 Apr; 256(1750):5. PubMed ID: 22792683
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic standards in Alzheimer disease.
    Doody RS
    Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S20-6. PubMed ID: 10622675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD; Zakzanis KK
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E and donepezil for the treatment of mild cognitive impairment.
    Marder K
    Curr Neurol Neurosci Rep; 2005 Sep; 5(5):337-8. PubMed ID: 16131415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.